GLOH yields 53.33% · MRK yields 2.76%● Live data
📍 GLOH pulled ahead of the other in Year 1
Combined, GLOH + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GLOH + MRK for your $10,000?
Glow Holdings Inc., a diversified holdings company, engages in retail packaged foods, hospitality business and consulting services, specialty foods franchising, wellness and health products, and mobile technology marketing development businesses. It offers mobile apps for enterprises and individuals seeking to use mobile devices as channels for personal and business branding. The company also engages in developing, branding, managing, and funding hotel and resort properties. In addition, it offers consumer packaged foods. Further, Glow Holdings Inc. is involved in the consumer food and beverage industry. The company was formerly known as GlobalOne Real Estate, Inc. and changed its name to Glow Holdings, Inc. in August 2011. The company was incorporated in 1997 and is based in Seattle, Washington.
Full GLOH Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.